4.7 Article

Effects of anoxic prognostic model on immune microenvironment in pancreatic cancer

Related references

Note: Only part of the references are listed.
Article Oncology

PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer

Yanjun Gao et al.

Summary: This study investigated the role and transcriptional regulation of PLAU in cervical cancer, finding that PLAU was overexpressed in cervical cancer and its suppression significantly inhibited cell migration and invasion. Additionally, YY1 was identified as a regulator of PLAU mRNA expression. These findings suggest the YY1/PLAU axis as a potential therapeutic target for cervical cancer.

ONCOLOGY REPORTS (2023)

Article Oncology

Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis

Haolan Wang et al.

Summary: Pancreatic adenocarcinoma (PAAD) is a common cause of death among solid tumors, and this study identified the value of immune/stromal-related genes in the prognosis of PAAD through comprehensive bioinformatics analysis and experimental validation, highlighting PLAU as a potential diagnostic and therapeutic target.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Article Immunology

Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)

S. M. Zahid Hosen et al.

Summary: Elevated PLAU expression is associated with aggressive phenotypes, stromal score, and immune suppression in PDAC. PLAU upregulation is closely associated with the basal subtype of PDAC, and patients with this subtype may benefit from therapeutic targeting of PLAU. The study also showed that even short-term PLAU inhibition is effective in halting tumor growth and eliminating visible metastasis in a clinically relevant orthotopic pancreatic model.

FRONTIERS IN IMMUNOLOGY (2022)

Review Oncology

Targeting hypoxic tumor microenvironment in pancreatic cancer

Jinxin Tao et al.

Summary: Pancreatic cancer, characterized by late diagnosis, early metastasis, and poor prognosis, exhibits high lethality globally. The hypoxic microenvironment in pancreatic cancer has extensive effects on biological behaviors and malignant phenotypes, leading to aggressive progression and therapeutic resistance. Innovative therapies targeting the tumor hypoxic microenvironment show great potential in overcoming treatment resistance and enhancing antitumor efficacy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms

Jan Korbecki et al.

Summary: This paper discusses the mechanisms and effects of chronic low-grade inflammation caused by chronic hypoxia and cycling hypoxia in malignant tumors, as well as their impact on the tumor microenvironment and cell recruitment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Hypoxia-induced FOXO4/LDHA axis modulates gastric cancer cell glycolysis and progression

Xiao-Hong Wang et al.

Summary: FOXO4 downregulation in gastric cancer is associated with poor prognosis. Restoring FOXO4 expression decreases glycolysis rate in GC cells, while silencing it increases glycolysis rate. FOXO4 is a transcriptional target of HIF-1 alpha and plays a key role in regulating glycolysis in GC.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Article Immunology

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma

Dongjie Chen et al.

Summary: By analyzing gene expression data of PDAC patients, we constructed a risk score model with seven signature genes that can effectively predict patient prognosis, stratifying patients into high-risk and low-risk groups. Patients in the low-risk group showed significantly better overall survival compared to those in the high-risk group.

FRONTIERS IN IMMUNOLOGY (2021)

Review Medicine, Research & Experimental

Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more

Xiaodong Hao et al.

Summary: Hypoxia is a common phenomenon in pancreatic cancer, leading to metabolic reprogramming of cancer cells and contributing to immunotherapy resistance.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Biotechnology & Applied Microbiology

Interferon alpha-inducible protein 27 (IFI27) is a prognostic marker for pancreatic cancer based on comprehensive bioinformatics analysis

Shu Huang et al.

Summary: The study revealed that elevated expression of IFI27 in pancreatic cancer tissues is associated with poor prognosis, potentially affecting the tumor microenvironment by regulating cellular immunity and metabolism.

BIOENGINEERED (2021)

Review Oncology

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Aaron J. Grossberg et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Medicine, General & Internal

Pancreatic cancer

Jonathan D Mizrahi et al.

LANCET (2020)

Review Biochemistry & Molecular Biology

The Immune Microenvironment in Pancreatic Cancer

Magdalena Huber et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity

Andrea Padoan et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Gastroenterology & Hepatology

Molecular subtypes of pancreatic cancer

Eric A. Collisson et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Review Pharmacology & Pharmacy

The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy

Najah Albadari et al.

EXPERT OPINION ON DRUG DISCOVERY (2019)

Review Oncology

Checkpoint inhibitors in pancreatic cancer

Andreas Henriksen et al.

CANCER TREATMENT REVIEWS (2019)

Article Multidisciplinary Sciences

ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer

Shigeru Hashimoto et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Gastroenterology & Hepatology

Therapeutic developments in pancreatic cancer: current and future perspectives

John P. Neoptolemos et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Review Oncology

Immunotherapy and Prevention of Pancreatic Cancer

Alexander H. Morrison et al.

TRENDS IN CANCER (2018)

Article Oncology

Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer

David Balli et al.

CLINICAL CANCER RESEARCH (2017)

Review Radiology, Nuclear Medicine & Medical Imaging

Data-Driven Prioritization and Review of Targets for Molecular-Based Theranostic Approaches in Pancreatic Cancer

Marjory Koller et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Oncology

The Pancreatic Cancer Microenvironment

Stephanie K. Dougan

CANCER JOURNAL (2017)

Review Oncology

HIF-1 at the crossroads of hypoxia, inflammation, and cancer

Kuppusamy Balamurugan

INTERNATIONAL JOURNAL OF CANCER (2016)

Review Oncology

Metabolic phenotype of bladder cancer

Francesco Massari et al.

CANCER TREATMENT REVIEWS (2016)

Review Oncology

Pancreatic cancer: yesterday, today and tomorrow

Daniel Ansari et al.

FUTURE ONCOLOGY (2016)

Article Gastroenterology & Hepatology

Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells

Oleksandr H. Minchenko et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Oncology

The Pancreas Cancer Microenvironment

Christine Feig et al.

CLINICAL CANCER RESEARCH (2012)

Article Medicine, General & Internal

Pancreatic cancer

Audrey Vincent et al.

LANCET (2011)

Article Immunology

Regulatory pathways in inflammation

Alberto Mantovani et al.

AUTOIMMUNITY REVIEWS (2007)

Review Surgery

Hypoxia and angiogenesis in pancreatic cancer

Giuseppe Garcea et al.

ANZ JOURNAL OF SURGERY (2006)

Review Cell Biology

HIF-1 and mechanisms of hypoxia sensing

GL Semenza

CURRENT OPINION IN CELL BIOLOGY (2001)